1.Ischemic colitis proximal to obstructing carcinoma of left colon: a report of one case report.
Byeong Wha JEONG ; Woo Bae PARK
Journal of the Korean Surgical Society 1993;45(5):894-899
No abstract available.
Colitis, Ischemic*
;
Colon*
2.A case of myasthenia gravis in pregnancy.
Byeong Jun CHEONG ; Hyoung Moo PARK ; Do Hwan BAE
Korean Journal of Obstetrics and Gynecology 1992;35(6):932-940
No abstract available.
Myasthenia Gravis*
;
Pregnancy*
5.A study on the regional blood flow of the hand.
Ki Jeong WON ; Byeong Il PARK ; Yong Bae KIM ; Woon Jae YANG ; Jong Sup PARK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(5):969-974
No abstract available.
Hand*
;
Regional Blood Flow*
6.An experimental study & clinical appliance of EMLA(eutectic mixture of local anesthetics).
Ki Jeong WON ; Yong Bae KIM ; Byeong Il PARK ; Yeong Man LEE ; Jong Sup PARK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(5):911-916
No abstract available.
7.Calcification in lung cancer: CT evaluation.
Jun Bae LEE ; Young Joon LEE ; Jong Hwa LEE ; Byeong Ho PARK ; Byung Soo KIM
Journal of the Korean Radiological Society 1991;27(3):368-372
No abstract available.
Lung Neoplasms*
;
Lung*
8.Otogenic cerebellar abscess: report of a case.
Byeong Il BAE ; Young Hwan SEO ; Woon Sang PARK ; Kwang Hyun CHUNG
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(4):596-599
No abstract available.
Abscess*
9.A case of leiomyoma occurred in scalp of retroauricular area.
Byeong Il BAE ; Woon Sang PARK ; Young Hwan SEO ; Kwang Hyun CHUNG
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(5):728-731
No abstract available.
Leiomyoma*
;
Scalp*
10.Cytotoxic Chemotherapy for Non-small Cell Lung Cancer.
Hanyang Medical Reviews 2014;34(1):31-36
Non-small-cell lung cancer is one of the leading causes of deaths from cancer worldwide. There have been remarkable advances in the targeted treatment of advanced non-small cell lung cancer (NSCLC) over the past several years. Survival outcomes are steadily improving as management paradigms shift in the diagnosis and treatment of advanced NSCLC. Customizing treatment based on histology and molecular typing has become a standard of care in this era of targeted therapy. Even as new chemotherapeutic agents are proving effective, a pivotal role for platinum-based chemotherapy doublets has been confirmed. Maintenance chemotherapy has become an option, but determining which patients will most benefit from it remains controversial in the real-world setting. Ongoing efforts to overcome resistance to targeted agents utilizing combination regimens of chemotherapy plus targeted agents, are currently being explored and optimized. This review highlights recent developments in novel chemotherapeutics. Despite advances in molecular medicine, there remains an essential role for chemotherapy in advanced NSCLC, even in the recent targeted therapy era.
Antineoplastic Agents
;
Carcinoma, Non-Small-Cell Lung*
;
Cause of Death
;
Chemotherapy, Adjuvant
;
Diagnosis
;
Drug Therapy*
;
Humans
;
Lung Neoplasms
;
Maintenance Chemotherapy
;
Molecular Medicine
;
Molecular Typing
;
Standard of Care
Result Analysis
Print
Save
E-mail